Screener
Solid Biosciences Inc. SLDB Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Solid Biosciences Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337935
FAQ
- What is Solid Biosciences Inc.'s current ratio?
- Solid Biosciences Inc. (SLDB) reported current ratio of 13.8× in Q2 2026.
- How has Solid Biosciences Inc.'s current ratio changed year-over-year?
- Solid Biosciences Inc.'s current ratio increased by 48.1% year-over-year, from 9.3× to 13.8×.
- What is the long-term trend for Solid Biosciences Inc.'s current ratio?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s current ratio has grown at a -1.1% compound annual growth rate (CAGR), from 6.5× to 6.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Solid Biosciences Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude